| Product Code: ETC7916501 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Neuroblastoma Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Neuroblastoma Market - Industry Life Cycle |
3.4 Latvia Neuroblastoma Market - Porter's Five Forces |
3.5 Latvia Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 Latvia Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Latvia Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Latvia Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about neuroblastoma and early detection methods |
4.2.2 Advances in medical technology and treatment options for neuroblastoma |
4.2.3 Growing investments in healthcare infrastructure and research for neuroblastoma |
4.3 Market Restraints |
4.3.1 High treatment costs associated with neuroblastoma |
4.3.2 Limited availability of specialized healthcare facilities for neuroblastoma treatment |
4.3.3 Challenges in accessing timely diagnosis and treatment for neuroblastoma patients |
5 Latvia Neuroblastoma Market Trends |
6 Latvia Neuroblastoma Market, By Types |
6.1 Latvia Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 Latvia Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 Latvia Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 Latvia Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 Latvia Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 Latvia Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Latvia Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 Latvia Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 Latvia Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 Latvia Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 Latvia Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 Latvia Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 Latvia Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Latvia Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 Latvia Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 Latvia Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 Latvia Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 Latvia Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Neuroblastoma Market Import-Export Trade Statistics |
7.1 Latvia Neuroblastoma Market Export to Major Countries |
7.2 Latvia Neuroblastoma Market Imports from Major Countries |
8 Latvia Neuroblastoma Market Key Performance Indicators |
8.1 Survival rate of neuroblastoma patients in Latvia |
8.2 Number of clinical trials and research studies conducted for neuroblastoma in Latvia |
8.3 Adoption rate of innovative treatment methods for neuroblastoma in Latvia |
9 Latvia Neuroblastoma Market - Opportunity Assessment |
9.1 Latvia Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 Latvia Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Latvia Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Latvia Neuroblastoma Market - Competitive Landscape |
10.1 Latvia Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 Latvia Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here